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that benefit more fromOR than EVAR. From this study we
cannot draw any conclusions about patients unfit for sur-
gery. Improved criteria for patient selection, including risk
stratification of consistent defined comorbidities, will bet-
ter help us to find those patients that will benefit from open
or endovascular AAA treatment.
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The Swedish Vascular Registry (Swedvasc) is a long standing
national project used for auditing outcome of a variety of vascular
procedures.1 The authors for the Swedish Vascular Registry
(Swedvasc) have assessed the outcome of endovascular repair in
patients at high-risk for surgical treatment of their abdominal
aortic aneurysm in comparison to open surgery. A comparison ofof co-morbid factors between treatment groups. The authors
selected two studies with a similar design for comparison with their
own series. The first study, a Veterans Administration study, was
reported by Bush et al and the second by Sicard et al.2,3 These US
studies both concluded from their operative and late mortality data
that patients with infrarenal abdominal aortic aneurysm with con-
siderable medical co-morbidities benefit from and should be con-
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Volume 48, Number 6 Buth et al 1389sidered for primary endovascular aneurysm repair (EVAR). The
authors of the Swedvasc study came to an opposite conclusion in
that they could “not confirm the benefit of EVAR from these
previous registry studies with a similar high-risk definition”, and
“in clinical practice, open repair may be at least as good as EVAR in
high-risk patients fit for surgery”. The conclusion was based on a
relatively high all-cause mortality in EVAR patients during follow-
up. However, a clear explanation for the striking difference of their
results with the two US studies was not provided. Causes of death
were not available in their database and “aneurysm-related death”
was disposed as an unreliable variable.
Despite a common definition for “high risk” there is consid-
erable leeway for selection bias to lead to noncomparability of
subgroups. Two-thirds of the Swedvasc patients had only one of a
range of possible conditions indicating unfitness. In their system,
the severity, for example, of cardiac problems ranged from a
successful aorto-coronary bypass graft (CABG) to manifest unsta-
ble angina or congestive heart failure. Most other co-morbid
conditions demonstrated a similar variation in severity. This system
indeed is imperfect. There is currently no better way to document
differences in risk profiles of subgroups than a posthoc comparison
of all-cause mortality rates after a follow-up period of 1 or more
years. After all, the majority of late deaths come from co-
morbidities, rather than from aneurysms or treatment-related
causes.4 The EVAR group in the Swedvasc study had a substan-
tially worse general health profile than patients treated by operative
repair (OR), considering all-causemortality rates varying from 41%
to 26% after 4 years, respectively. Similarly, fitness in EVAR pa-
tients in Swedvasc was inferior compared to those in the VA-study
(1-year mortality rates of 15.9% and 9.5%, respectively). The
opposite was true for patients with surgical treatment of theiraneurysm. Differences inmidterm all-causemortality rates strongly
suggested Swedvasc OR-patients to be in far better health at
baseline than patients studied by Bush and Sicard (8.5% vs 12.4%-
14% mortality at 1 year, 26% vs 34% mortality at 5 years). A more
favorablemedical risk profile in the Swedvasc patients withORmay
be associated with smaller, anatomically less complex aneurysms.4
These factors combined may explain the low 30-day mortality of
3.3%.
The authors had better concluded that differences in outcome
between treatment groups in their own study as well as compared
to other studies were primarily caused by factors related to patient
selection for each treatment.
REFERENCES
1. Bergqvist D, Troëng T, Elfström J, Hedberg B, Ljungström KG, Nor-
gren L, Ortenwall P. Auditing surgical outcome: ten years with the
Swedish Vascular Registry – Swedvasc. The Steering Committee of
Swedvasc. Eur J Surg Suppl 1998;581:3-8.
2. Bush RL, Johnson ML, Hedayati N, Henderson WG, Lin PH, Lumsden
AB. Performance of endovascular aortic aneurysm repair in high-risk
patients: results from the Veterans Affairs National Surgical Quality
Improvement Program. J Vasc Surg 2007;45:227-33.
3. Sicard GA, Zwolak RM, Sidawy AN, White RA, Siami FS. Society for
Vascular Surgery Outcomes Committee. Endovascular abdominal aortic
aneurysm repair: long-term outcomemeasures in patients at high-risk for
open surgery. J Vasc Surg 2006;44:229-36.
4. Buth J, vanMarrewijk CJ, Harris PL, HopWCJ, Riambau V, Laheij RJF,
the EUROSTAR collaborators. Outcome of endovascular abdominal
aortic aneurysm repair in patients with conditions considered unfit for an
open procedure. A report on the EUROSTAR experience. J Vasc Surg
2002;35:211-21.
